Additional takeaways to the slide content:
Smith & Nephew bone application work "going very well"
Novosorb US Medtech option evaluation period ends in Dec - maybe deal then.
OTC AOD9604 "confirming with US and Euro regulatory authorities" and "talking to potential customers and collaborators" will keep the market informed of progress.
Ann: Boardroom Radio , page-2
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)